Prescription medication · Azole Antifungal
isavuconazonium
Also sold as Cresemba. Cresemba treats invasive aspergillosis and invasive mucormycosis.
Data updated 2026-05-15
- 3,219
- FDA reportsLightly reported
- 9
- InteractionsFew interactions
- $107.94
- Brand price (NADAC)
What the data shows
isavuconazonium (Cresemba) is a prescription Azole Antifungal, among the least-reported drugs the FDA tracks (3,219 FDA reports), with 9 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
isavuconazonium (Cresemba) is a prescription Azole Antifungal. Cresemba treats invasive aspergillosis and invasive mucormycosis.
Cresemba is an antifungal medicine. It is used to treat serious fungal infections in adults and children.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$107.94/unit
Generic Available
No
ASTELLAS
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Cresemba treats invasive aspergillosis and invasive mucormycosis.
Common side effects
Nausea, Vomiting, Diarrhea
Key warnings
Cresemba can cause serious liver problems.
The sections below are summarized in plain English from isavuconazonium's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Cresemba belongs to a class of drugs called azole antifungals. It works by stopping the growth of the fungi. This helps your body fight off the infection.
How to Take It
Cresemba can be given as an injection or capsules. The injection is given into your vein over at least 1 hour. Capsules can be taken with or without food. Follow your doctor's instructions on how much and how often to take Cresemba.
This is a plain-language summary of isavuconazonium's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Cresemba can harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. Do not breastfeed while taking Cresemba.
This is a plain-language summary of isavuconazonium's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
This is a plain-language summary of isavuconazonium's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store Cresemba capsules at room temperature, away from moisture. Store Cresemba for injection in the refrigerator.
Side Effects (from patient reports)
Based on 3,219 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for isavuconazonium, by number of reports
- Death
Death
310 reports
- Feeling sick to your stomach
Feeling sick to your stomach
143 reports
- Fever with low white blood cell count
Fever with low white blood cell count
135 reports
- Fever
Fever
125 reports
- Lung infection 114
Lung infection
114 reports
- Condition getting worse 106
Condition getting worse
106 reports
- Feeling tired 101
Feeling tired
101 reports
- Loose stools 91
Loose stools
91 reports
- Difficulty breathing 87
Difficulty breathing
87 reports
- Medicine interacting with another medicine 84
Medicine interacting with another medicine
84 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for isavuconazonium each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where isavuconazonium sits
isavuconazonium has more FDA adverse-event reports than 19% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is isavuconazonium; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 3,219 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2015–2025.
Total Reports
3,219
Reports Mentioning Death
674
20.9% of reports — not proof of cause
Hospitalization Reports
1,032
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 2 | DEATH | 310 |
| 3 | NAUSEA | 143 |
| 4 | FEBRILE NEUTROPENIA | 135 |
| 6 | PYREXIA | 125 |
| 7 | PNEUMONIA | 114 |
| 8 | CONDITION AGGRAVATED | 106 |
| 9 | FATIGUE | 101 |
| 10 | DIARRHOEA | 91 |
| 11 | DYSPNOEA | 87 |
| 12 | DRUG INTERACTION | 84 |
| 13 | VOMITING | 81 |
| 15 | ACUTE KIDNEY INJURY | 70 |
| 16 | SEPSIS | 63 |
| 17 | PLATELET COUNT DECREASED | 59 |
| 18 | ASPERGILLUS INFECTION | 56 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Cresemba can cause serious liver problems. Your doctor will check your liver function before and during treatment. Cresemba can also cause allergic reactions. Tell your doctor right away if you have any signs of a reaction, like trouble breathing or skin rash. Cresemba can harm an unborn baby. Use birth control while taking this medicine.
Known Drug Interactions
Antihelminthics, Antifungals and Antiprotozoals Isavuconazonium Contraindicated during and 2 weeks after itraconazole treatment.
Mechanism: Itraconazole blocks the body's ability to break down isavuconazonium, which can cause the drug to reach unsafe levels.
What to do: Do not take these medicines together, and wait two weeks after stopping itraconazole before starting the new drug.
Atorvastatin Use with Caution Caution should be used when atorvastatin is used with CRESEMBA due to a potential increase in atorvastatin exposure. Monitor patients for adverse reactions that are typical of atorvastatin [see Clinical Pharmacology ( 12.3 )] .
Mechanism: Isavuconazonium can increase the amount of atorvastatin in your blood by slowing down how your body processes it. This can make you more likely to experience side effects from the cholesterol medicine.
What to do: Use this combination with caution and tell your doctor if you notice any new side effects like muscle pain.
Bupropion Use with Caution Concomitant administration of CRESEMBA and bupropion results in decrease in bupropion exposure. Dose increase of bupropion may be necessary when coadministered with CRESEMBA, but should not exceed the maximum recommended dose [see Clinical Pharmacology ( 12.3 )] .
Mechanism: Taking isavuconazonium can lower the amount of bupropion in your system, making the medication less effective. This happens because the body clears the drug faster than normal.
What to do: Your doctor may need to increase your dose of bupropion to ensure it still works correctly.
Cyclosporine Use with Caution Concomitant administration of CRESEMBA and cyclosporine results in increase in cyclosporine exposure. Monitor drug concentrations of cyclosporine and adjust dose as needed [see Clinical Pharmacology ( 12.3 )] . ( 7 ) • Appropriate therapeutic drug monitoring and dose adjustment of immunosuppressants (i.e., tacrolimus, sirolimus, and cyclosporine) may be necessary when coadministered with CRESEMBA.
Mechanism: Isavuconazonium causes cyclosporine to build up in your body by slowing its removal. This can lead to higher levels of the drug, which may cause harm.
What to do: Your doctor should monitor your cyclosporine blood levels and adjust your dose as needed.
Midazolam Use with Caution Concomitant administration of CRESEMBA and midazolam results in increase in midazolam exposure. Consider dose reduction of midazolam when isavuconazole is coadministered [see Clinical Pharmacology ( 12.3 )] .
Mechanism: Isavuconazonium slows down the breakdown of midazolam, which leads to higher levels of the sedative in your blood. This can make the drug's effects much stronger or last longer than intended.
What to do: Your doctor may need to reduce your dose of midazolam while you are taking these medications together.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
What should I tell my doctor before taking Cresemba?
Can I take other medicines with Cresemba?
How long will I need to take Cresemba?
What if I have infusion-related reactions?
What if I have abnormal liver tests?
What is the dose for adults?
What is the dose for children?
Can Cresemba cause any serious side effects?
What should I do if I think I have a side effect?
How should I store Cresemba?
What are the common side effects of isavuconazonium?
Does isavuconazonium interact with other medications?
What drug class is isavuconazonium?
Is isavuconazonium safe during pregnancy?
Related Medications in Azole Antifungal
Other drugs grouped near isavuconazonium - same-class peers and common alternatives.
acyclovir
Zovirax
Acyclovir is an antiviral medicine.
Compare with isavuconazonium →
albendazole
Albenza
Albendazole is a medicine that fights parasites.
Compare with isavuconazonium →
amphotericin B
Ambisome, Fungizone
Amphotericin B liposome is an antifungal medicine.
Compare with isavuconazonium →
anidulafungin
Eraxis
Eraxis is an antifungal medicine.
Compare with isavuconazonium →
atovaquone/proguanil
Malarone
Malarone is a drug used to prevent and treat malaria.
Compare with isavuconazonium →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on isavuconazonium
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for isavuconazonium
The FDA label for isavuconazonium (sold under brand names such as Cresemba) classifies it as a prescription-only medication in the Azole Antifungal class. Cresemba treats invasive aspergillosis and invasive mucormycosis. Official labeling lists 11 commonly reported side effects, including Nausea, Vomiting, Diarrhea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 3,219 voluntary reports. The database also lists 9 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: April 25, 2025
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages